[1]
Susanti, L.R., Mustika, A., Rahmawati, L.D. and Wungu, C.D.K. 2024. Efficacy and Safety of Ozoralizumab vs. Moxibustion for Rheumatoid Arthritis. Folia Medica Indonesiana. 60, 4 (Dec. 2024), 358–371. DOI:https://doi.org/10.20473/fmi.v60i4.64949.